Oncologists caution that at-home genetic tests taken up by millions of Americans looking to gauge their cancer risk are not ...

The laboratory can conduct pre-natal tests for genetic disorders like beta thalassaemia, sickle cell disease and other ...

In an update posted today, Neurogene said that the "emerging treatment-related serious adverse event (SAE)" was a case of ...

Researchers have developed a dual-gene therapy approach to treat Usher syndrome type 1F, a rare condition causing deafness and progressive blindness.

Neurogene is proceeding with a scaled-back study of its proposed NGN-401 gene therapy for the rare genetic neurological disorder Rett ... this month before the study setback, were recently down 7.3% ...

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

Ask yourself how the genetic test results may affect your life. If the results come back positive, will you take steps to ...

Local teen, Elliot Dougherty, will be traveling to Denver, Colorado as one of 18 models for the Global Down Syndrome ...

Denali Therapeutics' innovative approach to neurological disorders and strong financial strategy position it as a leader in ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

Alzheimer dementia occurs at higher rates among adults with Down syndrome with a mean onset at age 54.5 and a disease duration of 4.6 years.

The 18-year-old was born with Down syndrome, but that really didn’t change the way his parents raised him. Wes’ dad, Robert, says the genetic disorder is a limitation, cognitively and physically, but ...